Literature DB >> 6876111

Heterogeneity of osteogenesis imperfecta type I.

C R Paterson, S McAllion, R Miller.   

Abstract

We have studied 166 patients from 71 families with Sillence type I osteogenesis imperfecta (dominant inheritance and blue sclerae). We confirm earlier findings that there are two subgroups, those with and those without dentinogenesis imperfecta; each family can be allocated to one or other group. Our confidence that the two groups represent distinct disorders is increased by finding that the patients with dentinogenesis imperfecta differ not only in their dental characteristics but also in other clinical features. They have a more severe disease with a greater fracture rate and a greater likelihood of growth impairment.

Entities:  

Mesh:

Year:  1983        PMID: 6876111      PMCID: PMC1049046          DOI: 10.1136/jmg.20.3.203

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  8 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

2.  Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen.

Authors:  G S Barsh; K E David; P H Byers
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

3.  Scanning electron microscopy of teeth in dominant osteogenesis imperfecta: support for genetic heterogeneity.

Authors:  L S Levin; J M Brady; M Melnick
Journal:  Am J Med Genet       Date:  1980

4.  Osteogenesis imperfecta: biochemical and clinical evaluation of 13 cases.

Authors:  T Krieg; E Kirsch; K Matzen; P K Müller
Journal:  Klin Wochenschr       Date:  1981-01-15

5.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

6.  Osteogenesis imperfecta (lethal) bones contain types III and V collagens.

Authors:  F M Pope; A C Nicholls; C Eggleton; P Narcissi; E N Hey; J M Parkin
Journal:  J Clin Pathol       Date:  1980-06       Impact factor: 3.411

7.  The relative amounts of the collagen chains alpha 1(I), alpha 2 and alpha 1(III) in the skin of 31 patients with osteogenesis imperfecta.

Authors:  M J Francis; K J Williams; B C Sykes; R Smith
Journal:  Clin Sci (Lond)       Date:  1981-06       Impact factor: 6.124

8.  A defect in the structure of type I procollagen in a patient who had osteogenesis imperfecta: excess mannose in the COOH-terminal propeptide.

Authors:  L Peltonen; A Palotie; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

  8 in total
  10 in total

1.  Exclusion of the alpha 1(II) cartilage collagen gene as the mutant locus in type IA osteogenesis imperfecta.

Authors:  B Sykes; R Smith; S Vipond; C Paterson; K Cheah; E Solomon
Journal:  J Med Genet       Date:  1985-06       Impact factor: 6.318

2.  Osteogenesis imperfecta in the differential diagnosis of child abuse.

Authors:  C R Paterson; S J McAllion
Journal:  BMJ       Date:  1989-12-09

3.  Causes of death in osteogenesis imperfecta.

Authors:  S J McAllion; C R Paterson
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

4.  Osteogenesis imperfecta 1984.

Authors:  R Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

5.  Risk of dominant mutation in older fathers: evidence from osteogenesis imperfecta.

Authors:  A D Carothers; S J McAllion; C R Paterson
Journal:  J Med Genet       Date:  1986-06       Impact factor: 6.318

6.  Ocular characteristics and complications in patients with osteogenesis imperfecta: a systematic review.

Authors:  Sanne Treurniet; Pia Burger; Ebba A E Ghyczy; Frank D Verbraak; Katie R Curro-Tafili; Dimitra Micha; Nathalie Bravenboer; Stuart H Ralston; Ralph de Vries; Annette C Moll; Elisabeth Marelise W Eekhoff
Journal:  Acta Ophthalmol       Date:  2021-05-19       Impact factor: 3.988

Review 7.  Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment.

Authors:  F S Van Dijk; D O Sillence
Journal:  Am J Med Genet A       Date:  2014-04-08       Impact factor: 2.802

8.  Osteogenesis imperfecta: potential therapeutic approaches.

Authors:  Maxime Rousseau; Jean-Marc Retrouvey
Journal:  PeerJ       Date:  2018-08-17       Impact factor: 2.984

Review 9.  International Perspectives on Joint Hypermobility: A Synthesis of Current Science to Guide Clinical and Research Directions.

Authors:  Leslie L Nicholson; Jane Simmonds; Verity Pacey; Inge De Wandele; Lies Rombaut; Cylie M Williams; Cliffton Chan
Journal:  J Clin Rheumatol       Date:  2022-06-03       Impact factor: 3.902

10.  Novel mutation of FKBP10 in a pediatric patient with osteogenesis imperfecta type XI identified by clinical exome sequencing.

Authors:  Harvy Mauricio Velasco; Jessica L Morales
Journal:  Appl Clin Genet       Date:  2017-11-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.